Global Parkinson Treatment Drug Production, Demand and Key Producers, 2022-2028
This report studies the global Parkinson Treatment Drug demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Parkinson Treatment Drug, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2021 as the base year. This report explores demand trends and competition, as well as details the characteristics of Parkinson Treatment Drug that contribute to its increasing demand across many markets.
The global Parkinson Treatment Drug market size is expected to reach $ million by 2028, rising at a market growth of % CAGR during the forecast period (2022-2028).
Highlights and key features of the study
Global Parkinson Treatment Drug total market, 2017-2028, (USD Million)
Global Parkinson Treatment Drug total market by region & country, CAGR, 2017-2028, (USD Million)
U.S. VS China: Parkinson Treatment Drug total market, key domestic companies and share, (USD Million)
Global Parkinson Treatment Drug revenue by player and market share 2017-2022, (USD Million)
Global Parkinson Treatment Drug total market by Type, CAGR, 2017-2028, (USD Million)
Global Parkinson Treatment Drug total market by Application, CAGR, 2017-2028, (USD Million)
This reports profiles major players in the global Parkinson Treatment Drug market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck, Akorn, GSK, Novartis, Boehringer Ingelheim, Teva Pharmaceutical, Abbvie, Kyowa Hakko Kirin Pharma and Astellas Pharma, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Parkinson Treatment Drug market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2017-2028 by year with 2021 as the base year, 2022 as the estimate year, and 2028 as the forecast year.
Global Parkinson Treatment Drug Market, By Region:
1. How big is the global Parkinson Treatment Drug market?
2. What is the demand of the global Parkinson Treatment Drug market?
3. What is the year over year growth of the global Parkinson Treatment Drug market?
4. What is the total value of the global Parkinson Treatment Drug market?
5. Who are the major players in the global Parkinson Treatment Drug market?
6. What are the growth factors driving the market demand?
This report is a detailed and comprehensive analysis of the world market for Parkinson Treatment Drug, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2021 as the base year. This report explores demand trends and competition, as well as details the characteristics of Parkinson Treatment Drug that contribute to its increasing demand across many markets.
The global Parkinson Treatment Drug market size is expected to reach $ million by 2028, rising at a market growth of % CAGR during the forecast period (2022-2028).
Highlights and key features of the study
Global Parkinson Treatment Drug total market, 2017-2028, (USD Million)
Global Parkinson Treatment Drug total market by region & country, CAGR, 2017-2028, (USD Million)
U.S. VS China: Parkinson Treatment Drug total market, key domestic companies and share, (USD Million)
Global Parkinson Treatment Drug revenue by player and market share 2017-2022, (USD Million)
Global Parkinson Treatment Drug total market by Type, CAGR, 2017-2028, (USD Million)
Global Parkinson Treatment Drug total market by Application, CAGR, 2017-2028, (USD Million)
This reports profiles major players in the global Parkinson Treatment Drug market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck, Akorn, GSK, Novartis, Boehringer Ingelheim, Teva Pharmaceutical, Abbvie, Kyowa Hakko Kirin Pharma and Astellas Pharma, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Parkinson Treatment Drug market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2017-2028 by year with 2021 as the base year, 2022 as the estimate year, and 2028 as the forecast year.
Global Parkinson Treatment Drug Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Sinemet-CR
- Piribedil
- Madopar
- COMT Inhibitor
- Others
- Male Patient
- Female Patient
- Merck
- Akorn
- GSK
- Novartis
- Boehringer Ingelheim
- Teva Pharmaceutical
- Abbvie
- Kyowa Hakko Kirin Pharma
- Astellas Pharma
- Desitin Arzneimittel
- Endo Pharmaceuticals
- F.Hoffmann-La Roche
- H.Lundbeck
- Valeant
- Apokyn
- Orion
- Stada Arzneimittel
- US WorldMeds
- Bausch Health
1. How big is the global Parkinson Treatment Drug market?
2. What is the demand of the global Parkinson Treatment Drug market?
3. What is the year over year growth of the global Parkinson Treatment Drug market?
4. What is the total value of the global Parkinson Treatment Drug market?
5. Who are the major players in the global Parkinson Treatment Drug market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Parkinson Treatment Drug Introduction
1.2 World Parkinson Treatment Drug Market Size & Forecast (2017 & 2021 & 2028)
1.3 World Parkinson Treatment Drug Total Market by Region
1.3.1 World Parkinson Treatment Drug Market Size by Region (2017-2028)
1.3.2 United States Parkinson Treatment Drug Market Size (2017-2028)
1.3.3 China Parkinson Treatment Drug Market Size (2017-2028)
1.3.4 Europe Parkinson Treatment Drug Market Size (2017-2028)
1.3.5 Japan Parkinson Treatment Drug Market Size (2017-2028)
1.3.6 South Korea Parkinson Treatment Drug Market Size (2017-2028)
1.3.7 ASEAN Parkinson Treatment Drug Market Size (2017-2028)
1.3.8 India Parkinson Treatment Drug Market Size (2017-2028)
1.4 Market Drivers, Restraints and Trends
1.4.1 Parkinson Treatment Drug Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Parkinson Treatment Drug Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 WORLD PARKINSON TREATMENT DRUG COMPANIES COMPETITIVE ANALYSIS
2.1 World Parkinson Treatment Drug Revenue by Player (2017-2022)
2.2 Industry Rank and Concentration Rate (CR)
2.2.1 Global Parkinson Treatment Drug Industry Rank of Major Players
2.2.2 Global Concentration Ratios (CR4) for Parkinson Treatment Drug in 2021
2.2.3 Global Concentration Ratios (CR8) for Parkinson Treatment Drug in 2021
2.3 Parkinson Treatment Drug Company Evaluation Quadrant
2.4 Parkinson Treatment Drug Market: Overall Company Footprint Analysis
2.4.1 Parkinson Treatment Drug Market: Region Footprint
2.4.2 Parkinson Treatment Drug Market: Company Product Type Footprint
2.4.3 Parkinson Treatment Drug Market: Company Product Application Footprint
2.5 Competitive Environment
2.5.1 Historical Structure of the Industry
2.5.2 Barriers of Market Entry
2.5.3 Factors of Competition
2.6 Mergers, Acquisitions Activity
3 UNITED STATES VS CHINA VS REST OF THE WORLD
3.1 United States VS China: Parkinson Treatment Drug Market Comparison
3.1.1 United States VS China: Parkinson Treatment Drug Market Size Comparison (2017 & 2021 & 2028)
3.1.2 United States VS China: Parkinson Treatment Drug Market Size Market Share Comparison (2017 & 2021 & 2028)
3.2 United States Parkinson Treatment Drug Major Players and Market Share, 2017-2022
3.2.1 Major Players of Parkinson Treatment Drug in United States, Headquarters (States, Country)
3.2.2 United States Parkinson Treatment Drug Revenue by Domestic Player, (2017-2022)
3.3 China Parkinson Treatment Drug Major Players and Market Share, 2017-2022
3.3.1 Major Players of Parkinson Treatment Drug in China, Headquarters (Province, Country)
3.3.2 China Parkinson Treatment Drug Revenue by Domestic Player, (2017-2022)
3.4 Rest of World Parkinson Treatment Drug Major Players and Market Share, 2017-2022
3.4.1 Major Players of Parkinson Treatment Drug in Rest of World, Headquarters (State, Country)
3.4.2 Rest of World Parkinson Treatment Drug Revenue by Domestic Player, (2017-2022)
4 MARKET ANALYSIS BY TYPE
4.1 World Parkinson Treatment Drug Market Size Overview by Type: 2017 VS 2021 VS 2028
4.2 Segment Introduction by Type
4.2.1 Sinemet-CR
4.2.2 Piribedil
4.2.3 Madopar
4.2.4 COMT Inhibitor
4.2.5 Others
4.3 Market Segment by Type
4.3.1 World Parkinson Treatment Drug Market Size by Type (2017-2022)
4.3.2 World Parkinson Treatment Drug Market Size by Type (2023-2028)
4.3.3 World Parkinson Treatment Drug Market Size Market Share by Type (2017-2028)
5 MARKET ANALYSIS BY APPLICATION
5.1 World Parkinson Treatment Drug Market Size Overview by Application: 2017 VS 2021 VS 2028
5.2 Segment Introduction by Application
5.2.1 Male Patient
5.2.2 Female Patient
5.3 Market Segment by Application
5.3.1 World Parkinson Treatment Drug Market Size by Application (2017-2022)
5.3.2 World Parkinson Treatment Drug Market Size by Application (2023-2028)
5.3.3 World Parkinson Treatment Drug Market Size by Application (2017-2028)
6 COMPANY PROFILES
6.1 Merck
6.1.1 Merck Details
6.1.2 Merck Major Business
6.1.3 Merck Parkinson Treatment Drug Product and Services
6.1.4 Merck Parkinson Treatment Drug Revenue, Gross Margin and Market Share (2017-2022)
6.1.5 Merck Recent Developments/Updates
6.1.6 Merck Competitive Strengths & Weaknesses
6.2 Akorn
6.2.1 Akorn Details
6.2.2 Akorn Major Business
6.2.3 Akorn Parkinson Treatment Drug Product and Services
6.2.4 Akorn Parkinson Treatment Drug Revenue, Gross Margin and Market Share (2017-2022)
6.2.5 Akorn Recent Developments/Updates
6.2.6 Akorn Competitive Strengths & Weaknesses
6.3 GSK
6.3.1 GSK Details
6.3.2 GSK Major Business
6.3.3 GSK Parkinson Treatment Drug Product and Services
6.3.4 GSK Parkinson Treatment Drug Revenue, Gross Margin and Market Share (2017-2022)
6.3.5 GSK Recent Developments/Updates
6.3.6 GSK Competitive Strengths & Weaknesses
6.4 Novartis
6.4.1 Novartis Details
6.4.2 Novartis Major Business
6.4.3 Novartis Parkinson Treatment Drug Product and Services
6.4.4 Novartis Parkinson Treatment Drug Revenue, Gross Margin and Market Share (2017-2022)
6.4.5 Novartis Recent Developments/Updates
6.4.6 Novartis Competitive Strengths & Weaknesses
6.5 Boehringer Ingelheim
6.5.1 Boehringer Ingelheim Details
6.5.2 Boehringer Ingelheim Major Business
6.5.3 Boehringer Ingelheim Parkinson Treatment Drug Product and Services
6.5.4 Boehringer Ingelheim Parkinson Treatment Drug Revenue, Gross Margin and Market Share (2017-2022)
6.5.5 Boehringer Ingelheim Recent Developments/Updates
6.5.6 Boehringer Ingelheim Competitive Strengths & Weaknesses
6.6 Teva Pharmaceutical
6.6.1 Teva Pharmaceutical Details
6.6.2 Teva Pharmaceutical Major Business
6.6.3 Teva Pharmaceutical Parkinson Treatment Drug Product and Services
6.6.4 Teva Pharmaceutical Parkinson Treatment Drug Revenue, Gross Margin and Market Share (2017-2022)
6.6.5 Teva Pharmaceutical Recent Developments/Updates
6.6.6 Teva Pharmaceutical Competitive Strengths & Weaknesses
6.7 Abbvie
6.7.1 Abbvie Details
6.7.2 Abbvie Major Business
6.7.3 Abbvie Parkinson Treatment Drug Product and Services
6.7.4 Abbvie Parkinson Treatment Drug Revenue, Gross Margin and Market Share (2017-2022)
6.7.5 Abbvie Recent Developments/Updates
6.7.6 Abbvie Competitive Strengths & Weaknesses
6.8 Kyowa Hakko Kirin Pharma
6.8.1 Kyowa Hakko Kirin Pharma Details
6.8.2 Kyowa Hakko Kirin Pharma Major Business
6.8.3 Kyowa Hakko Kirin Pharma Parkinson Treatment Drug Product and Services
6.8.4 Kyowa Hakko Kirin Pharma Parkinson Treatment Drug Revenue, Gross Margin and Market Share (2017-2022)
6.8.5 Kyowa Hakko Kirin Pharma Recent Developments/Updates
6.8.6 Kyowa Hakko Kirin Pharma Competitive Strengths & Weaknesses
6.9 Astellas Pharma
6.9.1 Astellas Pharma Details
6.9.2 Astellas Pharma Major Business
6.9.3 Astellas Pharma Parkinson Treatment Drug Product and Services
6.9.4 Astellas Pharma Parkinson Treatment Drug Revenue, Gross Margin and Market Share (2017-2022)
6.9.5 Astellas Pharma Recent Developments/Updates
6.9.6 Astellas Pharma Competitive Strengths & Weaknesses
6.10 Desitin Arzneimittel
6.10.1 Desitin Arzneimittel Details
6.10.2 Desitin Arzneimittel Major Business
6.10.3 Desitin Arzneimittel Parkinson Treatment Drug Product and Services
6.10.4 Desitin Arzneimittel Parkinson Treatment Drug Revenue, Gross Margin and Market Share (2017-2022)
6.10.5 Desitin Arzneimittel Recent Developments/Updates
6.10.6 Desitin Arzneimittel Competitive Strengths & Weaknesses
6.11 Endo Pharmaceuticals
6.11.1 Endo Pharmaceuticals Details
6.11.2 Endo Pharmaceuticals Major Business
6.11.3 Endo Pharmaceuticals Parkinson Treatment Drug Product and Services
6.11.4 Endo Pharmaceuticals Parkinson Treatment Drug Revenue, Gross Margin and Market Share (2017-2022)
6.11.5 Endo Pharmaceuticals Recent Developments/Updates
6.11.6 Endo Pharmaceuticals Competitive Strengths & Weaknesses
6.12 F.Hoffmann-La Roche
6.12.1 F.Hoffmann-La Roche Details
6.12.2 F.Hoffmann-La Roche Major Business
6.12.3 F.Hoffmann-La Roche Parkinson Treatment Drug Product and Services
6.12.4 F.Hoffmann-La Roche Parkinson Treatment Drug Revenue, Gross Margin and Market Share (2017-2022)
6.12.5 F.Hoffmann-La Roche Recent Developments/Updates
6.12.6 F.Hoffmann-La Roche Competitive Strengths & Weaknesses
6.13 H.Lundbeck
6.13.1 H.Lundbeck Details
6.13.2 H.Lundbeck Major Business
6.13.3 H.Lundbeck Parkinson Treatment Drug Product and Services
6.13.4 H.Lundbeck Parkinson Treatment Drug Revenue, Gross Margin and Market Share (2017-2022)
6.13.5 H.Lundbeck Recent Developments/Updates
6.13.6 H.Lundbeck Competitive Strengths & Weaknesses
6.14 Valeant
6.14.1 Valeant Details
6.14.2 Valeant Major Business
6.14.3 Valeant Parkinson Treatment Drug Product and Services
6.14.4 Valeant Parkinson Treatment Drug Revenue, Gross Margin and Market Share (2017-2022)
6.14.5 Valeant Recent Developments/Updates
6.14.6 Valeant Competitive Strengths & Weaknesses
6.15 Apokyn
6.15.1 Apokyn Details
6.15.2 Apokyn Major Business
6.15.3 Apokyn Parkinson Treatment Drug Product and Services
6.15.4 Apokyn Parkinson Treatment Drug Revenue, Gross Margin and Market Share (2017-2022)
6.15.5 Apokyn Recent Developments/Updates
6.15.6 Apokyn Competitive Strengths & Weaknesses
6.16 Orion
6.16.1 Orion Details
6.16.2 Orion Major Business
6.16.3 Orion Parkinson Treatment Drug Product and Services
6.16.4 Orion Parkinson Treatment Drug Revenue, Gross Margin and Market Share (2017-2022)
6.16.5 Orion Recent Developments/Updates
6.16.6 Orion Competitive Strengths & Weaknesses
6.17 Stada Arzneimittel
6.17.1 Stada Arzneimittel Details
6.17.2 Stada Arzneimittel Major Business
6.17.3 Stada Arzneimittel Parkinson Treatment Drug Product and Services
6.17.4 Stada Arzneimittel Parkinson Treatment Drug Revenue, Gross Margin and Market Share (2017-2022)
6.17.5 Stada Arzneimittel Recent Developments/Updates
6.17.6 Stada Arzneimittel Competitive Strengths & Weaknesses
6.18 US WorldMeds
6.18.1 US WorldMeds Details
6.18.2 US WorldMeds Major Business
6.18.3 US WorldMeds Parkinson Treatment Drug Product and Services
6.18.4 US WorldMeds Parkinson Treatment Drug Revenue, Gross Margin and Market Share (2017-2022)
6.18.5 US WorldMeds Recent Developments/Updates
6.18.6 US WorldMeds Competitive Strengths & Weaknesses
6.19 Bausch Health
6.19.1 Bausch Health Details
6.19.2 Bausch Health Major Business
6.19.3 Bausch Health Parkinson Treatment Drug Product and Services
6.19.4 Bausch Health Parkinson Treatment Drug Revenue, Gross Margin and Market Share (2017-2022)
6.19.5 Bausch Health Recent Developments/Updates
6.19.6 Bausch Health Competitive Strengths & Weaknesses
7 RAW MATERIAL AND INDUSTRY CHAIN
7.1 Raw Material of Parkinson Treatment Drug and Key Manufacturers
7.2 Parkinson Treatment Drug Manufacturing Costs
7.3 Parkinson Treatment Drug Production Process
7.4 Parkinson Treatment Drug Industrial Chain
8 DISTRIBUTION CHANNEL ANALYSIS
8.1 Distribution Channel Breakdown for Parkinson Treatment Drug Shipments (%): 2017-2028
8.1.1 Direct Channel
8.1.2 Indirect Channel
8.2 Parkinson Treatment Drug Typical Distributors
8.3 Parkinson Treatment Drug Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Parkinson Treatment Drug Introduction
1.2 World Parkinson Treatment Drug Market Size & Forecast (2017 & 2021 & 2028)
1.3 World Parkinson Treatment Drug Total Market by Region
1.3.1 World Parkinson Treatment Drug Market Size by Region (2017-2028)
1.3.2 United States Parkinson Treatment Drug Market Size (2017-2028)
1.3.3 China Parkinson Treatment Drug Market Size (2017-2028)
1.3.4 Europe Parkinson Treatment Drug Market Size (2017-2028)
1.3.5 Japan Parkinson Treatment Drug Market Size (2017-2028)
1.3.6 South Korea Parkinson Treatment Drug Market Size (2017-2028)
1.3.7 ASEAN Parkinson Treatment Drug Market Size (2017-2028)
1.3.8 India Parkinson Treatment Drug Market Size (2017-2028)
1.4 Market Drivers, Restraints and Trends
1.4.1 Parkinson Treatment Drug Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Parkinson Treatment Drug Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 WORLD PARKINSON TREATMENT DRUG COMPANIES COMPETITIVE ANALYSIS
2.1 World Parkinson Treatment Drug Revenue by Player (2017-2022)
2.2 Industry Rank and Concentration Rate (CR)
2.2.1 Global Parkinson Treatment Drug Industry Rank of Major Players
2.2.2 Global Concentration Ratios (CR4) for Parkinson Treatment Drug in 2021
2.2.3 Global Concentration Ratios (CR8) for Parkinson Treatment Drug in 2021
2.3 Parkinson Treatment Drug Company Evaluation Quadrant
2.4 Parkinson Treatment Drug Market: Overall Company Footprint Analysis
2.4.1 Parkinson Treatment Drug Market: Region Footprint
2.4.2 Parkinson Treatment Drug Market: Company Product Type Footprint
2.4.3 Parkinson Treatment Drug Market: Company Product Application Footprint
2.5 Competitive Environment
2.5.1 Historical Structure of the Industry
2.5.2 Barriers of Market Entry
2.5.3 Factors of Competition
2.6 Mergers, Acquisitions Activity
3 UNITED STATES VS CHINA VS REST OF THE WORLD
3.1 United States VS China: Parkinson Treatment Drug Market Comparison
3.1.1 United States VS China: Parkinson Treatment Drug Market Size Comparison (2017 & 2021 & 2028)
3.1.2 United States VS China: Parkinson Treatment Drug Market Size Market Share Comparison (2017 & 2021 & 2028)
3.2 United States Parkinson Treatment Drug Major Players and Market Share, 2017-2022
3.2.1 Major Players of Parkinson Treatment Drug in United States, Headquarters (States, Country)
3.2.2 United States Parkinson Treatment Drug Revenue by Domestic Player, (2017-2022)
3.3 China Parkinson Treatment Drug Major Players and Market Share, 2017-2022
3.3.1 Major Players of Parkinson Treatment Drug in China, Headquarters (Province, Country)
3.3.2 China Parkinson Treatment Drug Revenue by Domestic Player, (2017-2022)
3.4 Rest of World Parkinson Treatment Drug Major Players and Market Share, 2017-2022
3.4.1 Major Players of Parkinson Treatment Drug in Rest of World, Headquarters (State, Country)
3.4.2 Rest of World Parkinson Treatment Drug Revenue by Domestic Player, (2017-2022)
4 MARKET ANALYSIS BY TYPE
4.1 World Parkinson Treatment Drug Market Size Overview by Type: 2017 VS 2021 VS 2028
4.2 Segment Introduction by Type
4.2.1 Sinemet-CR
4.2.2 Piribedil
4.2.3 Madopar
4.2.4 COMT Inhibitor
4.2.5 Others
4.3 Market Segment by Type
4.3.1 World Parkinson Treatment Drug Market Size by Type (2017-2022)
4.3.2 World Parkinson Treatment Drug Market Size by Type (2023-2028)
4.3.3 World Parkinson Treatment Drug Market Size Market Share by Type (2017-2028)
5 MARKET ANALYSIS BY APPLICATION
5.1 World Parkinson Treatment Drug Market Size Overview by Application: 2017 VS 2021 VS 2028
5.2 Segment Introduction by Application
5.2.1 Male Patient
5.2.2 Female Patient
5.3 Market Segment by Application
5.3.1 World Parkinson Treatment Drug Market Size by Application (2017-2022)
5.3.2 World Parkinson Treatment Drug Market Size by Application (2023-2028)
5.3.3 World Parkinson Treatment Drug Market Size by Application (2017-2028)
6 COMPANY PROFILES
6.1 Merck
6.1.1 Merck Details
6.1.2 Merck Major Business
6.1.3 Merck Parkinson Treatment Drug Product and Services
6.1.4 Merck Parkinson Treatment Drug Revenue, Gross Margin and Market Share (2017-2022)
6.1.5 Merck Recent Developments/Updates
6.1.6 Merck Competitive Strengths & Weaknesses
6.2 Akorn
6.2.1 Akorn Details
6.2.2 Akorn Major Business
6.2.3 Akorn Parkinson Treatment Drug Product and Services
6.2.4 Akorn Parkinson Treatment Drug Revenue, Gross Margin and Market Share (2017-2022)
6.2.5 Akorn Recent Developments/Updates
6.2.6 Akorn Competitive Strengths & Weaknesses
6.3 GSK
6.3.1 GSK Details
6.3.2 GSK Major Business
6.3.3 GSK Parkinson Treatment Drug Product and Services
6.3.4 GSK Parkinson Treatment Drug Revenue, Gross Margin and Market Share (2017-2022)
6.3.5 GSK Recent Developments/Updates
6.3.6 GSK Competitive Strengths & Weaknesses
6.4 Novartis
6.4.1 Novartis Details
6.4.2 Novartis Major Business
6.4.3 Novartis Parkinson Treatment Drug Product and Services
6.4.4 Novartis Parkinson Treatment Drug Revenue, Gross Margin and Market Share (2017-2022)
6.4.5 Novartis Recent Developments/Updates
6.4.6 Novartis Competitive Strengths & Weaknesses
6.5 Boehringer Ingelheim
6.5.1 Boehringer Ingelheim Details
6.5.2 Boehringer Ingelheim Major Business
6.5.3 Boehringer Ingelheim Parkinson Treatment Drug Product and Services
6.5.4 Boehringer Ingelheim Parkinson Treatment Drug Revenue, Gross Margin and Market Share (2017-2022)
6.5.5 Boehringer Ingelheim Recent Developments/Updates
6.5.6 Boehringer Ingelheim Competitive Strengths & Weaknesses
6.6 Teva Pharmaceutical
6.6.1 Teva Pharmaceutical Details
6.6.2 Teva Pharmaceutical Major Business
6.6.3 Teva Pharmaceutical Parkinson Treatment Drug Product and Services
6.6.4 Teva Pharmaceutical Parkinson Treatment Drug Revenue, Gross Margin and Market Share (2017-2022)
6.6.5 Teva Pharmaceutical Recent Developments/Updates
6.6.6 Teva Pharmaceutical Competitive Strengths & Weaknesses
6.7 Abbvie
6.7.1 Abbvie Details
6.7.2 Abbvie Major Business
6.7.3 Abbvie Parkinson Treatment Drug Product and Services
6.7.4 Abbvie Parkinson Treatment Drug Revenue, Gross Margin and Market Share (2017-2022)
6.7.5 Abbvie Recent Developments/Updates
6.7.6 Abbvie Competitive Strengths & Weaknesses
6.8 Kyowa Hakko Kirin Pharma
6.8.1 Kyowa Hakko Kirin Pharma Details
6.8.2 Kyowa Hakko Kirin Pharma Major Business
6.8.3 Kyowa Hakko Kirin Pharma Parkinson Treatment Drug Product and Services
6.8.4 Kyowa Hakko Kirin Pharma Parkinson Treatment Drug Revenue, Gross Margin and Market Share (2017-2022)
6.8.5 Kyowa Hakko Kirin Pharma Recent Developments/Updates
6.8.6 Kyowa Hakko Kirin Pharma Competitive Strengths & Weaknesses
6.9 Astellas Pharma
6.9.1 Astellas Pharma Details
6.9.2 Astellas Pharma Major Business
6.9.3 Astellas Pharma Parkinson Treatment Drug Product and Services
6.9.4 Astellas Pharma Parkinson Treatment Drug Revenue, Gross Margin and Market Share (2017-2022)
6.9.5 Astellas Pharma Recent Developments/Updates
6.9.6 Astellas Pharma Competitive Strengths & Weaknesses
6.10 Desitin Arzneimittel
6.10.1 Desitin Arzneimittel Details
6.10.2 Desitin Arzneimittel Major Business
6.10.3 Desitin Arzneimittel Parkinson Treatment Drug Product and Services
6.10.4 Desitin Arzneimittel Parkinson Treatment Drug Revenue, Gross Margin and Market Share (2017-2022)
6.10.5 Desitin Arzneimittel Recent Developments/Updates
6.10.6 Desitin Arzneimittel Competitive Strengths & Weaknesses
6.11 Endo Pharmaceuticals
6.11.1 Endo Pharmaceuticals Details
6.11.2 Endo Pharmaceuticals Major Business
6.11.3 Endo Pharmaceuticals Parkinson Treatment Drug Product and Services
6.11.4 Endo Pharmaceuticals Parkinson Treatment Drug Revenue, Gross Margin and Market Share (2017-2022)
6.11.5 Endo Pharmaceuticals Recent Developments/Updates
6.11.6 Endo Pharmaceuticals Competitive Strengths & Weaknesses
6.12 F.Hoffmann-La Roche
6.12.1 F.Hoffmann-La Roche Details
6.12.2 F.Hoffmann-La Roche Major Business
6.12.3 F.Hoffmann-La Roche Parkinson Treatment Drug Product and Services
6.12.4 F.Hoffmann-La Roche Parkinson Treatment Drug Revenue, Gross Margin and Market Share (2017-2022)
6.12.5 F.Hoffmann-La Roche Recent Developments/Updates
6.12.6 F.Hoffmann-La Roche Competitive Strengths & Weaknesses
6.13 H.Lundbeck
6.13.1 H.Lundbeck Details
6.13.2 H.Lundbeck Major Business
6.13.3 H.Lundbeck Parkinson Treatment Drug Product and Services
6.13.4 H.Lundbeck Parkinson Treatment Drug Revenue, Gross Margin and Market Share (2017-2022)
6.13.5 H.Lundbeck Recent Developments/Updates
6.13.6 H.Lundbeck Competitive Strengths & Weaknesses
6.14 Valeant
6.14.1 Valeant Details
6.14.2 Valeant Major Business
6.14.3 Valeant Parkinson Treatment Drug Product and Services
6.14.4 Valeant Parkinson Treatment Drug Revenue, Gross Margin and Market Share (2017-2022)
6.14.5 Valeant Recent Developments/Updates
6.14.6 Valeant Competitive Strengths & Weaknesses
6.15 Apokyn
6.15.1 Apokyn Details
6.15.2 Apokyn Major Business
6.15.3 Apokyn Parkinson Treatment Drug Product and Services
6.15.4 Apokyn Parkinson Treatment Drug Revenue, Gross Margin and Market Share (2017-2022)
6.15.5 Apokyn Recent Developments/Updates
6.15.6 Apokyn Competitive Strengths & Weaknesses
6.16 Orion
6.16.1 Orion Details
6.16.2 Orion Major Business
6.16.3 Orion Parkinson Treatment Drug Product and Services
6.16.4 Orion Parkinson Treatment Drug Revenue, Gross Margin and Market Share (2017-2022)
6.16.5 Orion Recent Developments/Updates
6.16.6 Orion Competitive Strengths & Weaknesses
6.17 Stada Arzneimittel
6.17.1 Stada Arzneimittel Details
6.17.2 Stada Arzneimittel Major Business
6.17.3 Stada Arzneimittel Parkinson Treatment Drug Product and Services
6.17.4 Stada Arzneimittel Parkinson Treatment Drug Revenue, Gross Margin and Market Share (2017-2022)
6.17.5 Stada Arzneimittel Recent Developments/Updates
6.17.6 Stada Arzneimittel Competitive Strengths & Weaknesses
6.18 US WorldMeds
6.18.1 US WorldMeds Details
6.18.2 US WorldMeds Major Business
6.18.3 US WorldMeds Parkinson Treatment Drug Product and Services
6.18.4 US WorldMeds Parkinson Treatment Drug Revenue, Gross Margin and Market Share (2017-2022)
6.18.5 US WorldMeds Recent Developments/Updates
6.18.6 US WorldMeds Competitive Strengths & Weaknesses
6.19 Bausch Health
6.19.1 Bausch Health Details
6.19.2 Bausch Health Major Business
6.19.3 Bausch Health Parkinson Treatment Drug Product and Services
6.19.4 Bausch Health Parkinson Treatment Drug Revenue, Gross Margin and Market Share (2017-2022)
6.19.5 Bausch Health Recent Developments/Updates
6.19.6 Bausch Health Competitive Strengths & Weaknesses
7 RAW MATERIAL AND INDUSTRY CHAIN
7.1 Raw Material of Parkinson Treatment Drug and Key Manufacturers
7.2 Parkinson Treatment Drug Manufacturing Costs
7.3 Parkinson Treatment Drug Production Process
7.4 Parkinson Treatment Drug Industrial Chain
8 DISTRIBUTION CHANNEL ANALYSIS
8.1 Distribution Channel Breakdown for Parkinson Treatment Drug Shipments (%): 2017-2028
8.1.1 Direct Channel
8.1.2 Indirect Channel
8.2 Parkinson Treatment Drug Typical Distributors
8.3 Parkinson Treatment Drug Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Parkinson Treatment Drug Market Size by Region (2017, 2022 and 2028) & (USD Million)
Table 2. World Parkinson Treatment Drug Market Size by Region (2017-2022) & (USD Million)
Table 3. World Parkinson Treatment Drug Market Size by Region (2023-2028) & (USD Million)
Table 4. World Parkinson Treatment Drug Market Size Market Share by Region (2017-2022)
Table 5. World Parkinson Treatment Drug Market Size Market Share by Region (2023-2028)
Table 6. Major Market Trends
Table 7. World Parkinson Treatment Drug Revenue by Player (2017-2022) & (USD Million)
Table 8. Revenue Market Share of Key Parkinson Treatment Drug Players in 2021
Table 9. World Parkinson Treatment Drug Industry Rank of Major Player, Based on Revenue in 2021
Table 10. Global Parkinson Treatment Drug Company Evaluation Quadrant
Table 11. Head Office of Key Parkinson Treatment Drug Player
Table 12. Parkinson Treatment Drug Market: Company Product Type Footprint
Table 13. Parkinson Treatment Drug Market: Company Product Application Footprint
Table 14. Parkinson Treatment Drug Mergers & Acquisitions Activity
Table 15. United States VS China Parkinson Treatment Drug Market Size Comparison, (2017 & 2021 & 2028) & (USD Million)
Table 16. Major Player of Parkinson Treatment Drug in United States, Headquarters (States, Country)
Table 17. United States Parkinson Treatment Drug Revenue by Domestic Player, (2017-2022) & (USD Million)
Table 18. United States Parkinson Treatment Drug Revenue Market Share by Domestic Player, (2017-2022)
Table 19. Major Player of Parkinson Treatment Drug in China, Company Headquarters (Province, Country)
Table 20. China Parkinson Treatment Drug Revenue by Domestic Player, (2017-2022) & (USD Million)
Table 21. China Parkinson Treatment Drug Revenue Market Share by Domestic Player, (2017-2022)
Table 22. Major Player of Parkinson Treatment Drug in Rest of World, Company Headquarters (State, Country)
Table 23. Rest of World Parkinson Treatment Drug Revenue by Domestic Player, (2017-2022) & (USD Million)
Table 24. Rest of World Parkinson Treatment Drug Revenue Market Share by Domestic Player, (2017-2022)
Table 25. World Parkinson Treatment Drug Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 26. World Parkinson Treatment Drug Revenue by Type (2017-2022) & (USD Million)
Table 27. World Parkinson Treatment Drug Revenue by Type (2023-2028) & (USD Million)
Table 28. World Parkinson Treatment Drug Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 29. World Parkinson Treatment Drug Revenue by Application (2017-2022) & (USD Million)
Table 30. World Parkinson Treatment Drug Revenue by Application (2023-2028) & (USD Million)
Table 31. Merck Basic Information, Area Served and Competitors
Table 32. Merck Major Business
Table 33. Merck Parkinson Treatment Drug Product and Services
Table 34. Merck Parkinson Treatment Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 35. Merck Recent Developments/Updates
Table 36. Merck Competitive Strengths & Weaknesses
Table 37. Akorn Basic Information, Area Served and Competitors
Table 38. Akorn Major Business
Table 39. Akorn Parkinson Treatment Drug Product and Services
Table 40. Akorn Parkinson Treatment Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 41. Akorn Recent Developments/Updates
Table 42. Akorn Competitive Strengths & Weaknesses
Table 43. GSK Basic Information, Area Served and Competitors
Table 44. GSK Major Business
Table 45. GSK Parkinson Treatment Drug Product and Services
Table 46. GSK Parkinson Treatment Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 47. GSK Recent Developments/Updates
Table 48. GSK Competitive Strengths & Weaknesses
Table 49. Novartis Basic Information, Area Served and Competitors
Table 50. Novartis Major Business
Table 51. Novartis Parkinson Treatment Drug Product and Services
Table 52. Novartis Parkinson Treatment Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 53. Novartis Recent Developments/Updates
Table 54. Novartis Competitive Strengths & Weaknesses
Table 55. Boehringer Ingelheim Basic Information, Area Served and Competitors
Table 56. Boehringer Ingelheim Major Business
Table 57. Boehringer Ingelheim Parkinson Treatment Drug Product and Services
Table 58. Boehringer Ingelheim Parkinson Treatment Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 59. Boehringer Ingelheim Recent Developments/Updates
Table 60. Boehringer Ingelheim Competitive Strengths & Weaknesses
Table 61. Teva Pharmaceutical Basic Information, Area Served and Competitors
Table 62. Teva Pharmaceutical Major Business
Table 63. Teva Pharmaceutical Parkinson Treatment Drug Product and Services
Table 64. Teva Pharmaceutical Parkinson Treatment Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 65. Teva Pharmaceutical Recent Developments/Updates
Table 66. Teva Pharmaceutical Competitive Strengths & Weaknesses
Table 67. Abbvie Basic Information, Area Served and Competitors
Table 68. Abbvie Major Business
Table 69. Abbvie Parkinson Treatment Drug Product and Services
Table 70. Abbvie Parkinson Treatment Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 71. Abbvie Recent Developments/Updates
Table 72. Abbvie Competitive Strengths & Weaknesses
Table 73. Kyowa Hakko Kirin Pharma Basic Information, Area Served and Competitors
Table 74. Kyowa Hakko Kirin Pharma Major Business
Table 75. Kyowa Hakko Kirin Pharma Parkinson Treatment Drug Product and Services
Table 76. Kyowa Hakko Kirin Pharma Parkinson Treatment Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 77. Kyowa Hakko Kirin Pharma Recent Developments/Updates
Table 78. Kyowa Hakko Kirin Pharma Competitive Strengths & Weaknesses
Table 79. Astellas Pharma Basic Information, Area Served and Competitors
Table 80. Astellas Pharma Major Business
Table 81. Astellas Pharma Parkinson Treatment Drug Product and Services
Table 82. Astellas Pharma Parkinson Treatment Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 83. Astellas Pharma Recent Developments/Updates
Table 84. Astellas Pharma Competitive Strengths & Weaknesses
Table 85. Desitin Arzneimittel Basic Information, Area Served and Competitors
Table 86. Desitin Arzneimittel Major Business
Table 87. Desitin Arzneimittel Parkinson Treatment Drug Product and Services
Table 88. Desitin Arzneimittel Parkinson Treatment Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 89. Desitin Arzneimittel Recent Developments/Updates
Table 90. Desitin Arzneimittel Competitive Strengths & Weaknesses
Table 91. Endo Pharmaceuticals Basic Information, Area Served and Competitors
Table 92. Endo Pharmaceuticals Major Business
Table 93. Endo Pharmaceuticals Parkinson Treatment Drug Product and Services
Table 94. Endo Pharmaceuticals Parkinson Treatment Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 95. Endo Pharmaceuticals Recent Developments/Updates
Table 96. Endo Pharmaceuticals Competitive Strengths & Weaknesses
Table 97. F.Hoffmann-La Roche Basic Information, Area Served and Competitors
Table 98. F.Hoffmann-La Roche Major Business
Table 99. F.Hoffmann-La Roche Parkinson Treatment Drug Product and Services
Table 100. F.Hoffmann-La Roche Parkinson Treatment Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 101. F.Hoffmann-La Roche Recent Developments/Updates
Table 102. F.Hoffmann-La Roche Competitive Strengths & Weaknesses
Table 103. H.Lundbeck Basic Information, Area Served and Competitors
Table 104. H.Lundbeck Major Business
Table 105. H.Lundbeck Parkinson Treatment Drug Product and Services
Table 106. H.Lundbeck Parkinson Treatment Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 107. H.Lundbeck Recent Developments/Updates
Table 108. H.Lundbeck Competitive Strengths & Weaknesses
Table 109. Valeant Basic Information, Area Served and Competitors
Table 110. Valeant Major Business
Table 111. Valeant Parkinson Treatment Drug Product and Services
Table 112. Valeant Parkinson Treatment Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 113. Valeant Recent Developments/Updates
Table 114. Valeant Competitive Strengths & Weaknesses
Table 115. Apokyn Basic Information, Area Served and Competitors
Table 116. Apokyn Major Business
Table 117. Apokyn Parkinson Treatment Drug Product and Services
Table 118. Apokyn Parkinson Treatment Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 119. Apokyn Recent Developments/Updates
Table 120. Apokyn Competitive Strengths & Weaknesses
Table 121. Orion Basic Information, Area Served and Competitors
Table 122. Orion Major Business
Table 123. Orion Parkinson Treatment Drug Product and Services
Table 124. Orion Parkinson Treatment Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 125. Orion Recent Developments/Updates
Table 126. Orion Competitive Strengths & Weaknesses
Table 127. Stada Arzneimittel Basic Information, Area Served and Competitors
Table 128. Stada Arzneimittel Major Business
Table 129. Stada Arzneimittel Parkinson Treatment Drug Product and Services
Table 130. Stada Arzneimittel Parkinson Treatment Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 131. Stada Arzneimittel Recent Developments/Updates
Table 132. Stada Arzneimittel Competitive Strengths & Weaknesses
Table 133. US WorldMeds Basic Information, Area Served and Competitors
Table 134. US WorldMeds Major Business
Table 135. US WorldMeds Parkinson Treatment Drug Product and Services
Table 136. US WorldMeds Parkinson Treatment Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 137. US WorldMeds Recent Developments/Updates
Table 138. Bausch Health Basic Information, Area Served and Competitors
Table 139. Bausch Health Major Business
Table 140. Bausch Health Parkinson Treatment Drug Product and Services
Table 141. Bausch Health Parkinson Treatment Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 142. Parkinson Treatment Drug Raw Material
Table 143. Key Manufacturers of Parkinson Treatment Drug Raw Materials
Table 144. Parkinson Treatment Drug Typical Distributors
Table 145. Parkinson Treatment Drug Typical Customers
Table 1. World Parkinson Treatment Drug Market Size by Region (2017, 2022 and 2028) & (USD Million)
Table 2. World Parkinson Treatment Drug Market Size by Region (2017-2022) & (USD Million)
Table 3. World Parkinson Treatment Drug Market Size by Region (2023-2028) & (USD Million)
Table 4. World Parkinson Treatment Drug Market Size Market Share by Region (2017-2022)
Table 5. World Parkinson Treatment Drug Market Size Market Share by Region (2023-2028)
Table 6. Major Market Trends
Table 7. World Parkinson Treatment Drug Revenue by Player (2017-2022) & (USD Million)
Table 8. Revenue Market Share of Key Parkinson Treatment Drug Players in 2021
Table 9. World Parkinson Treatment Drug Industry Rank of Major Player, Based on Revenue in 2021
Table 10. Global Parkinson Treatment Drug Company Evaluation Quadrant
Table 11. Head Office of Key Parkinson Treatment Drug Player
Table 12. Parkinson Treatment Drug Market: Company Product Type Footprint
Table 13. Parkinson Treatment Drug Market: Company Product Application Footprint
Table 14. Parkinson Treatment Drug Mergers & Acquisitions Activity
Table 15. United States VS China Parkinson Treatment Drug Market Size Comparison, (2017 & 2021 & 2028) & (USD Million)
Table 16. Major Player of Parkinson Treatment Drug in United States, Headquarters (States, Country)
Table 17. United States Parkinson Treatment Drug Revenue by Domestic Player, (2017-2022) & (USD Million)
Table 18. United States Parkinson Treatment Drug Revenue Market Share by Domestic Player, (2017-2022)
Table 19. Major Player of Parkinson Treatment Drug in China, Company Headquarters (Province, Country)
Table 20. China Parkinson Treatment Drug Revenue by Domestic Player, (2017-2022) & (USD Million)
Table 21. China Parkinson Treatment Drug Revenue Market Share by Domestic Player, (2017-2022)
Table 22. Major Player of Parkinson Treatment Drug in Rest of World, Company Headquarters (State, Country)
Table 23. Rest of World Parkinson Treatment Drug Revenue by Domestic Player, (2017-2022) & (USD Million)
Table 24. Rest of World Parkinson Treatment Drug Revenue Market Share by Domestic Player, (2017-2022)
Table 25. World Parkinson Treatment Drug Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 26. World Parkinson Treatment Drug Revenue by Type (2017-2022) & (USD Million)
Table 27. World Parkinson Treatment Drug Revenue by Type (2023-2028) & (USD Million)
Table 28. World Parkinson Treatment Drug Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 29. World Parkinson Treatment Drug Revenue by Application (2017-2022) & (USD Million)
Table 30. World Parkinson Treatment Drug Revenue by Application (2023-2028) & (USD Million)
Table 31. Merck Basic Information, Area Served and Competitors
Table 32. Merck Major Business
Table 33. Merck Parkinson Treatment Drug Product and Services
Table 34. Merck Parkinson Treatment Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 35. Merck Recent Developments/Updates
Table 36. Merck Competitive Strengths & Weaknesses
Table 37. Akorn Basic Information, Area Served and Competitors
Table 38. Akorn Major Business
Table 39. Akorn Parkinson Treatment Drug Product and Services
Table 40. Akorn Parkinson Treatment Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 41. Akorn Recent Developments/Updates
Table 42. Akorn Competitive Strengths & Weaknesses
Table 43. GSK Basic Information, Area Served and Competitors
Table 44. GSK Major Business
Table 45. GSK Parkinson Treatment Drug Product and Services
Table 46. GSK Parkinson Treatment Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 47. GSK Recent Developments/Updates
Table 48. GSK Competitive Strengths & Weaknesses
Table 49. Novartis Basic Information, Area Served and Competitors
Table 50. Novartis Major Business
Table 51. Novartis Parkinson Treatment Drug Product and Services
Table 52. Novartis Parkinson Treatment Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 53. Novartis Recent Developments/Updates
Table 54. Novartis Competitive Strengths & Weaknesses
Table 55. Boehringer Ingelheim Basic Information, Area Served and Competitors
Table 56. Boehringer Ingelheim Major Business
Table 57. Boehringer Ingelheim Parkinson Treatment Drug Product and Services
Table 58. Boehringer Ingelheim Parkinson Treatment Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 59. Boehringer Ingelheim Recent Developments/Updates
Table 60. Boehringer Ingelheim Competitive Strengths & Weaknesses
Table 61. Teva Pharmaceutical Basic Information, Area Served and Competitors
Table 62. Teva Pharmaceutical Major Business
Table 63. Teva Pharmaceutical Parkinson Treatment Drug Product and Services
Table 64. Teva Pharmaceutical Parkinson Treatment Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 65. Teva Pharmaceutical Recent Developments/Updates
Table 66. Teva Pharmaceutical Competitive Strengths & Weaknesses
Table 67. Abbvie Basic Information, Area Served and Competitors
Table 68. Abbvie Major Business
Table 69. Abbvie Parkinson Treatment Drug Product and Services
Table 70. Abbvie Parkinson Treatment Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 71. Abbvie Recent Developments/Updates
Table 72. Abbvie Competitive Strengths & Weaknesses
Table 73. Kyowa Hakko Kirin Pharma Basic Information, Area Served and Competitors
Table 74. Kyowa Hakko Kirin Pharma Major Business
Table 75. Kyowa Hakko Kirin Pharma Parkinson Treatment Drug Product and Services
Table 76. Kyowa Hakko Kirin Pharma Parkinson Treatment Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 77. Kyowa Hakko Kirin Pharma Recent Developments/Updates
Table 78. Kyowa Hakko Kirin Pharma Competitive Strengths & Weaknesses
Table 79. Astellas Pharma Basic Information, Area Served and Competitors
Table 80. Astellas Pharma Major Business
Table 81. Astellas Pharma Parkinson Treatment Drug Product and Services
Table 82. Astellas Pharma Parkinson Treatment Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 83. Astellas Pharma Recent Developments/Updates
Table 84. Astellas Pharma Competitive Strengths & Weaknesses
Table 85. Desitin Arzneimittel Basic Information, Area Served and Competitors
Table 86. Desitin Arzneimittel Major Business
Table 87. Desitin Arzneimittel Parkinson Treatment Drug Product and Services
Table 88. Desitin Arzneimittel Parkinson Treatment Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 89. Desitin Arzneimittel Recent Developments/Updates
Table 90. Desitin Arzneimittel Competitive Strengths & Weaknesses
Table 91. Endo Pharmaceuticals Basic Information, Area Served and Competitors
Table 92. Endo Pharmaceuticals Major Business
Table 93. Endo Pharmaceuticals Parkinson Treatment Drug Product and Services
Table 94. Endo Pharmaceuticals Parkinson Treatment Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 95. Endo Pharmaceuticals Recent Developments/Updates
Table 96. Endo Pharmaceuticals Competitive Strengths & Weaknesses
Table 97. F.Hoffmann-La Roche Basic Information, Area Served and Competitors
Table 98. F.Hoffmann-La Roche Major Business
Table 99. F.Hoffmann-La Roche Parkinson Treatment Drug Product and Services
Table 100. F.Hoffmann-La Roche Parkinson Treatment Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 101. F.Hoffmann-La Roche Recent Developments/Updates
Table 102. F.Hoffmann-La Roche Competitive Strengths & Weaknesses
Table 103. H.Lundbeck Basic Information, Area Served and Competitors
Table 104. H.Lundbeck Major Business
Table 105. H.Lundbeck Parkinson Treatment Drug Product and Services
Table 106. H.Lundbeck Parkinson Treatment Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 107. H.Lundbeck Recent Developments/Updates
Table 108. H.Lundbeck Competitive Strengths & Weaknesses
Table 109. Valeant Basic Information, Area Served and Competitors
Table 110. Valeant Major Business
Table 111. Valeant Parkinson Treatment Drug Product and Services
Table 112. Valeant Parkinson Treatment Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 113. Valeant Recent Developments/Updates
Table 114. Valeant Competitive Strengths & Weaknesses
Table 115. Apokyn Basic Information, Area Served and Competitors
Table 116. Apokyn Major Business
Table 117. Apokyn Parkinson Treatment Drug Product and Services
Table 118. Apokyn Parkinson Treatment Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 119. Apokyn Recent Developments/Updates
Table 120. Apokyn Competitive Strengths & Weaknesses
Table 121. Orion Basic Information, Area Served and Competitors
Table 122. Orion Major Business
Table 123. Orion Parkinson Treatment Drug Product and Services
Table 124. Orion Parkinson Treatment Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 125. Orion Recent Developments/Updates
Table 126. Orion Competitive Strengths & Weaknesses
Table 127. Stada Arzneimittel Basic Information, Area Served and Competitors
Table 128. Stada Arzneimittel Major Business
Table 129. Stada Arzneimittel Parkinson Treatment Drug Product and Services
Table 130. Stada Arzneimittel Parkinson Treatment Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 131. Stada Arzneimittel Recent Developments/Updates
Table 132. Stada Arzneimittel Competitive Strengths & Weaknesses
Table 133. US WorldMeds Basic Information, Area Served and Competitors
Table 134. US WorldMeds Major Business
Table 135. US WorldMeds Parkinson Treatment Drug Product and Services
Table 136. US WorldMeds Parkinson Treatment Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 137. US WorldMeds Recent Developments/Updates
Table 138. Bausch Health Basic Information, Area Served and Competitors
Table 139. Bausch Health Major Business
Table 140. Bausch Health Parkinson Treatment Drug Product and Services
Table 141. Bausch Health Parkinson Treatment Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 142. Parkinson Treatment Drug Raw Material
Table 143. Key Manufacturers of Parkinson Treatment Drug Raw Materials
Table 144. Parkinson Treatment Drug Typical Distributors
Table 145. Parkinson Treatment Drug Typical Customers
LIST OF FIGURES
Figure 1. Parkinson Treatment Drug Picture
Figure 2. World Parkinson Treatment Drug Total Market Size: 2017 & 2021 & 2028, (USD Million)
Figure 3. World Parkinson Treatment Drug Total Market Size (2017-2028) & (USD Million)
Figure 4. World Parkinson Treatment Drug Market Size Market Share by Region (2017-2028)
Figure 5. United States Parkinson Treatment Drug Market Size (2017-2028) & (USD Million)
Figure 6. China Parkinson Treatment Drug Market Size (2017-2028) & (USD Million)
Figure 7. Europe Parkinson Treatment Drug Market Size (2017-2028) & (USD Million)
Figure 8. Japan Parkinson Treatment Drug Market Size (2017-2028) & (USD Million)
Figure 9. South Korea Parkinson Treatment Drug Market Size (2017-2028) & (USD Million)
Figure 10. ASEAN Parkinson Treatment Drug Market Size (2017-2028) & (USD Million)
Figure 11. India Parkinson Treatment Drug Market Size (2017-2028) & (USD Million)
Figure 12. Parkinson Treatment Drug Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. Producer Shipments of Parkinson Treatment Drug by Player Revenue ($MM) and Market Share (%): 2021
Figure 15. Global Four-firm Concentration Ratios (CR4) for Parkinson Treatment Drug Markets in 2021
Figure 16. Global Four-firm Concentration Ratios (CR8) for Parkinson Treatment Drug Markets in 2021
Figure 17. United States VS China: Parkinson Treatment Drug Market Size Market Share Comparison (2017 & 2021 & 2028)
Figure 18. World Parkinson Treatment Drug Market Size by Type, (USD Million), 2017 & 2021 & 2028
Figure 19. World Parkinson Treatment Drug Market Size Market Share by Type in 2021
Figure 20. Sinemet-CR
Figure 21. Piribedil
Figure 22. Madopar
Figure 23. COMT Inhibitor
Figure 24. Others
Figure 25. World Parkinson Treatment Drug Market Size Market Share by Type (2017-2028)
Figure 26. World Parkinson Treatment Drug Market Size by Application, (USD Million), 2017 & 2021 & 2028
Figure 27. World Parkinson Treatment Drug Market Size Market Share by Application in 2021
Figure 28. Male Patient
Figure 29. Female Patient
Figure 30. World Parkinson Treatment Drug Market Size Market Share by Application (2017-2028)
Figure 31. Manufacturing Cost Structure Analysis of Parkinson Treatment Drug in 2021
Figure 32. Manufacturing Process Analysis of Parkinson Treatment Drug
Figure 33. Parkinson Treatment Drug Industrial Chain
Figure 34. Distribution Channel Breakdown for Parkinson Treatment Drug Shipments (%): 2017-2028
Figure 35. Direct Channel Pros & Cons
Figure 36. Indirect Channel Pros & Cons
Figure 37. Methodology
Figure 38. Research Process and Data Source
Figure 1. Parkinson Treatment Drug Picture
Figure 2. World Parkinson Treatment Drug Total Market Size: 2017 & 2021 & 2028, (USD Million)
Figure 3. World Parkinson Treatment Drug Total Market Size (2017-2028) & (USD Million)
Figure 4. World Parkinson Treatment Drug Market Size Market Share by Region (2017-2028)
Figure 5. United States Parkinson Treatment Drug Market Size (2017-2028) & (USD Million)
Figure 6. China Parkinson Treatment Drug Market Size (2017-2028) & (USD Million)
Figure 7. Europe Parkinson Treatment Drug Market Size (2017-2028) & (USD Million)
Figure 8. Japan Parkinson Treatment Drug Market Size (2017-2028) & (USD Million)
Figure 9. South Korea Parkinson Treatment Drug Market Size (2017-2028) & (USD Million)
Figure 10. ASEAN Parkinson Treatment Drug Market Size (2017-2028) & (USD Million)
Figure 11. India Parkinson Treatment Drug Market Size (2017-2028) & (USD Million)
Figure 12. Parkinson Treatment Drug Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. Producer Shipments of Parkinson Treatment Drug by Player Revenue ($MM) and Market Share (%): 2021
Figure 15. Global Four-firm Concentration Ratios (CR4) for Parkinson Treatment Drug Markets in 2021
Figure 16. Global Four-firm Concentration Ratios (CR8) for Parkinson Treatment Drug Markets in 2021
Figure 17. United States VS China: Parkinson Treatment Drug Market Size Market Share Comparison (2017 & 2021 & 2028)
Figure 18. World Parkinson Treatment Drug Market Size by Type, (USD Million), 2017 & 2021 & 2028
Figure 19. World Parkinson Treatment Drug Market Size Market Share by Type in 2021
Figure 20. Sinemet-CR
Figure 21. Piribedil
Figure 22. Madopar
Figure 23. COMT Inhibitor
Figure 24. Others
Figure 25. World Parkinson Treatment Drug Market Size Market Share by Type (2017-2028)
Figure 26. World Parkinson Treatment Drug Market Size by Application, (USD Million), 2017 & 2021 & 2028
Figure 27. World Parkinson Treatment Drug Market Size Market Share by Application in 2021
Figure 28. Male Patient
Figure 29. Female Patient
Figure 30. World Parkinson Treatment Drug Market Size Market Share by Application (2017-2028)
Figure 31. Manufacturing Cost Structure Analysis of Parkinson Treatment Drug in 2021
Figure 32. Manufacturing Process Analysis of Parkinson Treatment Drug
Figure 33. Parkinson Treatment Drug Industrial Chain
Figure 34. Distribution Channel Breakdown for Parkinson Treatment Drug Shipments (%): 2017-2028
Figure 35. Direct Channel Pros & Cons
Figure 36. Indirect Channel Pros & Cons
Figure 37. Methodology
Figure 38. Research Process and Data Source
